Renninger Robert — SEC Form 4 filings
SEC reporting owner CIK 2037968. 9 Form 4 filings on record with FilingPulse; latest filed 2026-04-13.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2024-10-03 to 2026-04-13. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 4 legs across 4 filings — 6,981 shares, $9,378 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 19.
- Largest priced transaction: sale of 906 shares @ $5.37 ($4,865) in LeonaBio, Inc., filed 2026-03-05.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| LeonaBio, Inc. (LONA) | CHIEF FINANCIAL OFFICER | 9 | — | 4 legs · 6,981 sh · $9,378 | 19 |
Form 4 filings — Renninger Robert
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-04-13 | 4 | LeonaBio, Inc. (LONA) | Grant/award (A): 300,000 (derivative) @ $0 | EDGAR |
| 2026-03-05 | 4 | LeonaBio, Inc. (LONA) | Option exercise (M): 3,900 @ $0 · Sale (S): 906 @ $5.37 · Option exercise (M): 3,900 (derivative) @ $0 | EDGAR |
| 2026-01-05 | 4 | Athira Pharma, Inc. (ATHA) | Grant/award (A): 1,000 @ $2.31 · Option exercise (M): 1,236 @ $0 · Sale (S): 297 @ $6.88 · Option exercise (M): 1,236 (derivative) @ $0 | EDGAR |
| 2025-12-29 | 4 | Athira Pharma, Inc. (ATHA) | Grant/award (A): 34,358 (derivative) @ $0 | EDGAR |
| 2025-07-02 | 4 | Athira Pharma, Inc. (ATHA) | Grant/award (A): 10,000 @ $0.23 · Option exercise (M): 12,359 @ $0 · Sale (S): 2,897 @ $0.29 · Option exercise (M): 12,359 (derivative) @ $0 | EDGAR |
| 2025-03-12 | 4/A | Athira Pharma, Inc. (ATHA) | Grant/award (A): 73,350 (derivative) @ $0 | EDGAR |
| 2025-03-04 | 4 | Athira Pharma, Inc. (ATHA) | Grant/award (A): 58,500 (derivative) @ $0 · Grant/award (A): 73,350 (derivative) @ $0 · Grant/award (A): 39,000 (derivative) @ $0 | EDGAR |
| 2025-01-03 | 4 | Athira Pharma, Inc. (ATHA) | Grant/award (A): 3,651 @ $0.55 · Option exercise (M): 12,359 @ $0 · Sale (S): 2,881 @ $0.56 · Option exercise (M): 12,359 (derivative) @ $0 | EDGAR |
| 2024-10-03 | 4 | Athira Pharma, Inc. (ATHA) | Grant/award (A): 37,077 (derivative) @ $0 · Grant/award (A): 37,077 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2037968 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →